GlycoErase™ HEK293T B3GALT6 Knockout Cell Line

To advance the study of glycosylation within the Golgi apparatus, we are pleased to present a B3GALT6 knockout HEK293T cell line. This cell line, deficient in the B3GALT6-encoded beta-1,3-galactosyltransferase 6, provides a unique opportunity to investigate the role of this enzyme in glycosylation processes within the Golgi. By utilizing HEK293T cells, a platform known for its robust support of gene function and regulation studies, researchers can gain a deeper understanding of the intricacies of Golgi-related glycosylation.

KO Cell Lines

Human

Epithelial-like, adherent

1:2~1:4

HEK293T

Embryonic kidney

>90%

The sterility test indicated an absence of microbial growth.

STR identification

Negative

Negative for HIV, HBV and HCV.

We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.

PCR, Sanger Sequencing

DMEM & FBS & Penicillin/Streptomycin

Functional assay

1 M cells/vial*2

Frozen

Dry ice

Made to order

Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.

This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

B3GALT6

Beta-1,3-galactosyltransferase 6

beta3GalT6

1p36.33

Beta-1,3-galactosyltransferase in the medial Golgi apparatus that catalyzes the transfer of galactose to substrates with a terminal beta-linked galactose moiety.